Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- A More Focused Highly Defensive Index
Dec 03, 2008 09:48 AM
- Achillion Pharma: Funding in Place to Advance HCV Pipeline
Nov 24, 2008 11:28 PM
- Enzon Pharma Shares Rise on Prospects
Nov 21, 2008 04:38 PM
- Five Healthcare Stocks To Diversify Your Portfolio
Nov 18, 2008 10:19 AM
- Rigel Pharmaceuticals– Crisis Or Opportunity?
Nov 10, 2008 09:57 AM
- Stocks Holding Up in Medical Sector
Oct 30, 2008 05:28 PM
- Gilead Offers Opportunities - Analyst Blog
Oct 20, 2008 11:04 AM
- Buffett Says The Time To Start Buying Is Now
Oct 17, 2008 11:55 AM
- Thursday’s Market Recap (10/16/2008)
Oct 16, 2008 11:20 PM
- Notable Earnings After Market Close (10/16/2008)
Oct 16, 2008 09:11 AM
- Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411
Dec 04, 2008 08:01 AM
- Data Demonstrating Significant Efficacy of Viread® in Treating Chronic Hepatitis B Published in New England Journal of Medicine
Dec 03, 2008 05:01 PM
- Gilead Sciences to Present at Two Upcoming Investor Conferences
Nov 25, 2008 04:16 PM
- Gilead Sciences Announces Notification of ANDA Filing for Truvada
Nov 14, 2008 04:32 PM
- Deloitte Unveils 2008 Technology Fast 500 Ranking
Nov 12, 2008 08:04 AM
- Gilead Sciences to Present at Three Upcoming Investor Conferences
Nov 05, 2008 04:29 PM
- Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B
Nov 01, 2008 11:01 AM
- Technologies, Markets and the Competitive Environment of Drug Delivery Using Nanotechnologies Explored
Oct 31, 2008 11:56 PM
- Technologies, Markets and the Competitive Environment of Drug Delivery Using Nanotechnologies Explored
Oct 31, 2008 06:56 AM
- Gilead Sciences to Present at the Oppenheimer 19th Annual Healthcare Conference on Tuesday, November 4
Oct 30, 2008 04:35 PM
- Form 4 MILLIGAN JOHN F For: Dec 01 (10K)
Dec 03, 2008 06:01 PM
- Form 4 BISCHOFBERGER NORBERT W For: Nov 19 (10K)
Nov 21, 2008 03:06 PM
- Form 4 DAVIGNON ETIENNE For: Nov 18 (10K)
Nov 20, 2008 12:24 PM
- Form 4 GILEAD SCIENCES INC For: Nov 12 Filed by: BERG PAUL (10K)
Nov 14, 2008 12:11 PM
- Form 4 GILEAD SCIENCES INC For: Nov 07 Filed by: BISCHOFBERGER NORBERT W (10K)
Nov 12, 2008 12:00 PM
- Form 4 GILEAD SCIENCES INC For: Nov 03 Filed by: Alton Gregg H (10K)
Nov 05, 2008 02:14 PM
- Form 4 GILEAD SCIENCES INC For: Oct 30 Filed by: BERG PAUL (10K)
Oct 31, 2008 07:47 PM
- Form 4 GILEAD SCIENCES INC For: Oct 24 Filed by: DAVIGNON ETIENNE (10K)
Oct 28, 2008 05:25 PM
- Form 4 GILEAD SCIENCES INC For: Oct 21 Filed by: DENNY JAMES M (10K)
Oct 23, 2008 07:09 PM
- Form 4 GILEAD SCIENCES INC For: Oct 15 Filed by: Alton Gregg H (10K)
Oct 17, 2008 04:00 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
GILD
|
Compare to S&P
|
| YTD |
0.35 %
|
-0.01 %
|
| 4 Weeks |
2.55 %
|
12.22 %
|
| 12 Weeks |
-1.39 %
|
39.53 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 10.64 %
|
|
EPS Growth in Last Year: 23.81 %
|
|
Sales Growth in Last Quarter: 7.29 %
|
|
Sales Growth in Last Quarter: 29.51 %
|
|
|
